31 results
DSM5 Diagnostic Criteria for Delirium #Diagnosis #IM #Delirium #DSM5 #NEJM
Delirium #Diagnosis #IM ... Delirium #DSM5 #NEJM
Approaches to Evaluating Kidney Disease in Patients with HIV Infection #Pathophys #Nephro #IM #HIV #CKD #AKI
Pathophys #Nephro #IM ... HIV #CKD #AKI #NEJM
IgM and Non-IgM - Risk and Type of Progression #EBM #Honc #MGUS #Progression #IgM #NonIgM #MultipleMyeloma
IgM and Non-IgM ... Progression #EBM #Honc #MGUS ... #Progression #IgM ... MultipleMyeloma #NEJM
Gonococcal Infections (Gonorrhea) - CDC 2021 Treatment Guidelines
Recommended Regimen:
 • Uncomplicated infections of the cervix, urethra,
ceftriaxone 500 mg IM ... IM in a single ... IM or by IV every ... exceed 250 mg IM ... for adults • Ocular
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
PrimaryCare #EM #IM ... Lightheadedness #Table #NEJM
Paraproteinemias

Entities That Can Feature A Monoclonal Protein/M Component:
• MM
• WM
• MGUS
• MGCS
• MGRS
• Splenic Marginal Zone
• MM • WM • MGUS ... • MGCSMGRS ... Hypergammaglobulinemic macular ... anemia due to cold IgG ... anticoagulant • IgM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Points #EBM #Neuro #IM ... Fremanezumab #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Cumulative Incidence of Progression of MGUS, with Death Accounted for as a Competing Risk #EBM #Honc
Progression of MGUS ... Risk #EBM #Honc #MGUS ... #Progression #IgG ... #MGUS #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Group #EBM #Neuro #IM ... Fremanezumab #Migraine #CGRP ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Points #EBM #Neuro #IM ... Fremanezumab #Migraine #CGRP ... CalcitoninGeneRelatedPeptideAntibody #NEJM